GlassScriptPhysician profile
Michel Pare
NPI 1912089533
$3,163.77
in general payments reported to CMS, 2019-2025
20 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.05 · 2020: $410 · 2021: $996 · 2022: $893 · 2023: $408 · 2024: $218 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $471.02 | 2020-2022 | |
| Globus Medical, INC. | $448.73 | 2021-2022 | |
| Medtronic, INC. | $428.21 | 2021-2025 | Mazor X System, Aquamantys(Tm), Intellis Adaptivestim |
| Abbott Laboratories | $384.33 | 2022-2025 | Proclaim, Eterna |
| 4web, INC. | $144.09 | 2020 | |
| Stryker Corporation | $140.59 | 2020-2023 | Vitoss |
| Smith+Nephew, INC. | $126.15 | 2024 | Pico, Renasys Touch |
| Aegis Spine, INC. | $123.66 | 2020 | |
| Nuvasive, INC. | $121.90 | 2021 | |
| Aesculap, INC. | $120.09 | 2020-2021 | |
| Bioventus LLC | $98.45 | 2021 | |
| Sun Pharmaceutical Industries INC. | $97.50 | 2023-2024 | Ilumya |
| Leica Microsystems INC. | $91.16 | 2025 | |
| Biotissue Holdings INC. | $90.76 | 2021 | |
| Kuros Biosciences USA, INC | $75.68 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $62.86 | 2022 | |
| Boston Scientific Corporation | $59.62 | 2023 | |
| Integra Lifesciences Corporation | $44.80 | 2020-2024 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Olympus America INC. | $19.05 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michel Pare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.